< Back to latest news & events

Event

Webinar: Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan

November 2021

Event date: 1st December 2021

Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan’.

About the webinar

Digital transformation has been reshaping the pharmaceutical industry. Today, AI has helped explore novel uses of existing drugs, develop new drugs, and accelerate R&D activity in the industry.

In Japan, patent eligibility of AI-related inventions is less strict than that in EP practice. When AI has been applied to pharmaceuticals, issues on inventive step, support requirements, and enable requirements often arise as points to be overcome.

Our speakers will explain patent eligibility on combinations of AI and pharmaceutical inventions, suggesting some practical points of the JPO Examination Guidelines. They will then give listeners insight into some case examples of AI-related pharmaceutical patents in Japan.

Watch the webinar: 

Speakers

Dr. Masato Iida, Shiga

Fumio Takahashi, Shiga

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T1977/22: Can claims defined by open-ended ranges ever be sufficiently disclosed?

The EPO’s Board of Appeal’s decision in T1977/22 provides an interesting review of the case law concerning the compatibility of whole range sufficiency and claims defined as a result to …

Read article

The draft of The Genetic Technology (Precision Breeding) Regulations 2025 reveals practical details on how to obtain a Precision Bred Organism status

In a recent blog post we discussed the Precision Breeding Regulatory Framework developed by the Food Standards Agency (FSA). Further details on the application process for Precision Bred Organism confirmation …

Read article

A £2.1M Lesson: The Power of Confidential Information

A recent High Court ruling1 serves as a stark reminder of the importance of respecting confidential business information. Hambro Perks, was found guilty of breaching confidentiality and ordered to pay …

Read article
Event - 6th March 2025

IQPC Global IP Exchange Europe 2025

HGF is sponsoring the IQPC Global IP Exchange Europe, which will be held on the 11th-12th March 2025 in Meliá, Berlin. Head of Electronics, Chris Benson, will be chairing the …

Event details

IP Ingredients: Pouring Over the Verdict: What Thatchers v Aldi Means for Food & Drink Brands

Readers of our IP Ingredients blog may recall that we covered something of this case last summer in our post IP Ingredients: Summer case law review. The dispute between Thatchers …

Read article

Protecting inventions in Europe and beyond

A patent is  a form of registered intellectual property right granted for new, inventive and industrially applicable inventions. Patents are monopoly rights that  allow their owners (or licensees) the right …

Read article
See all updates